HighTower Advisors »

Apellis Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $695k 12k 59.87

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)

View all positions for HighTower Advisors

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
Jennison Associates
Octagon Capital Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Assenagon Asset Management
Logos Global Management
Boxer Capital
Artal Group
Citadel Advisors
Caption Management
Norges Bank Investment Management

View all funds holding Apellis Pharmaceuticals